Q: Could you please comment on Bruker Corporation in US. Growth, debt, valuation.
Would you buy it today?
Thanks,
Milan
Would you buy it today?
Thanks,
Milan
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Hello Folks:
Could you please give me your view on Merck and Company (which along with Smith- Kline) has had problems executing new drugs (eg. lung cancer medications) in their pipelines. I also have previously owned Gilead, whose new HIV drug was reduced in value because of government pricing restrictions. My other health care equities are Johnson and Johnson and Knight Therapeutics. Do you think there are better health industry options (with decent dividends and growth potential) in the U.S. other than companies such as Merck, Gilead etc. or should one look to another sector.
Thanks for everything
brian
Could you please give me your view on Merck and Company (which along with Smith- Kline) has had problems executing new drugs (eg. lung cancer medications) in their pipelines. I also have previously owned Gilead, whose new HIV drug was reduced in value because of government pricing restrictions. My other health care equities are Johnson and Johnson and Knight Therapeutics. Do you think there are better health industry options (with decent dividends and growth potential) in the U.S. other than companies such as Merck, Gilead etc. or should one look to another sector.
Thanks for everything
brian
Q: If confidence is high on GUD, am I better to buy some July 2018 calls?
Q: Good Morning, while reading IBD I came across the company ABMD Abiomed and it peaked my interest. Could I get your opinion knowing the US is not your focus area. Thank you
Q: The price of ASP has increased around 200% in the last few days. Is there any reason for this increase and would you think it is a good buy?
Thank you
Thank you
Q: Is there an ETF that covers the cannibis companies?
Q: Good afternoon 5i team,
I have been looking into tax loss buying and keep coming back to your high view of Knight Therapeutics. It seems that a good deal of your views on the stock depends upon management. And in looking into the stock a little, it does seem that Jonathan Goodman is a kind of Wayne Gretzky in the business world. A rich kit who did well:). Here in Montréal he also recognized as an important philanthropist. A couple questions I have that I would appreciate your seasoned view on:
The CFO left but he doesn't seem to be just any CFO. he was also it seems a kind of founding partner of Knight. His position has been taken by the former CF O of Paladin, so that is good. But, he does seem to have been more than a CFO. I notice that the company that he moved to has become increasingly closer to Knight. So, I was wondering whether this was perhaps a strategic move by both companies. But, perhaps I am reading too much into it. You probably have heard more about this change than I would have and so I would appreciate you view on both the loss and the possibility of a strategic move.
Secondly, it seems that Jonathan Goodman is all - important at GUD. He has had an accident and although he seems to be, as he says, 'Almost' as good as ever, there is still a question there. He seems to have the intelligence to find a small but lucrative niche in this field and has the strength and selling ability to make the most of it. He looks good. But, what if he goes? I am not sure but I believe you mentioned in your report that the actual cash that they hold would cushion against that eventuality. Am I right in that understanding?
And heck, since it is Black Friday, I will throw another question in for free: You say that patience is needed. He says that it is going to take twenty years. Many of us are beginning to see twenty years as a pretty big number and we may not be here to see the tree grow. So, is it a good investment for the older crew? But, maybe like the old apple tree, we are better to plant one for the next generation.
thanks
I have been looking into tax loss buying and keep coming back to your high view of Knight Therapeutics. It seems that a good deal of your views on the stock depends upon management. And in looking into the stock a little, it does seem that Jonathan Goodman is a kind of Wayne Gretzky in the business world. A rich kit who did well:). Here in Montréal he also recognized as an important philanthropist. A couple questions I have that I would appreciate your seasoned view on:
The CFO left but he doesn't seem to be just any CFO. he was also it seems a kind of founding partner of Knight. His position has been taken by the former CF O of Paladin, so that is good. But, he does seem to have been more than a CFO. I notice that the company that he moved to has become increasingly closer to Knight. So, I was wondering whether this was perhaps a strategic move by both companies. But, perhaps I am reading too much into it. You probably have heard more about this change than I would have and so I would appreciate you view on both the loss and the possibility of a strategic move.
Secondly, it seems that Jonathan Goodman is all - important at GUD. He has had an accident and although he seems to be, as he says, 'Almost' as good as ever, there is still a question there. He seems to have the intelligence to find a small but lucrative niche in this field and has the strength and selling ability to make the most of it. He looks good. But, what if he goes? I am not sure but I believe you mentioned in your report that the actual cash that they hold would cushion against that eventuality. Am I right in that understanding?
And heck, since it is Black Friday, I will throw another question in for free: You say that patience is needed. He says that it is going to take twenty years. Many of us are beginning to see twenty years as a pretty big number and we may not be here to see the tree grow. So, is it a good investment for the older crew? But, maybe like the old apple tree, we are better to plant one for the next generation.
thanks
Q: SIS just broke through resistance of 17.40 or so on a little above average volume on Friday, even though the US market was only open half the day.
Would you think it would be a good time to add a little here given its all time high or wait to see if it cools off a little first?
Thanks
Jeff
Would you think it would be a good time to add a little here given its all time high or wait to see if it cools off a little first?
Thanks
Jeff
Q: RE: Peter Lynchs' general positivity about spin offs.
Opinion about the new spin off Viemed from PHM. Do you know if any of the old management from PHM will be involved with the new company or will it be fresh people from outside rather then some reshuffling of the old mismanaging guard?
Do know how the arrangement will work wrt shares. I don't own any PHM at the moment. Would there be any benefit of purchasing any before the split?
Thanks
Opinion about the new spin off Viemed from PHM. Do you know if any of the old management from PHM will be involved with the new company or will it be fresh people from outside rather then some reshuffling of the old mismanaging guard?
Do know how the arrangement will work wrt shares. I don't own any PHM at the moment. Would there be any benefit of purchasing any before the split?
Thanks
Q: Can I get your opinion of Biosyent (RX)? Thanks.
Q: What are your thoughts on the Q3 results? Thanks
Q: Would QYLD appropriate for USD income given very high current tech valuations? Are there any US health care etfs that generate income writing covered calls? Thank you
Q: I know you do not endorse buying cannibis stocks at this point in time, but I fear that I may be missing the boat. What is your opinion on buying a cannibis ETF? And which one would you prefer? Thanks for your help!
Q: Kudos to your new website, it’s very user friendly and a good tool for the small DIY investor!
My inquiry is on a Canadian Healthcare ETF (HHL) which I find interesting in that it includes US companies such as Novartis, Stryker, Medtronic, Johnson & Johnson and Anthem in the top 10 holdings, indicated dividend is north of 8.00%!
Also, if one is to hold it in a TFSA would the dividends be subject to the 15% foreign withholding tax?
Thnx for your great service!!
My inquiry is on a Canadian Healthcare ETF (HHL) which I find interesting in that it includes US companies such as Novartis, Stryker, Medtronic, Johnson & Johnson and Anthem in the top 10 holdings, indicated dividend is north of 8.00%!
Also, if one is to hold it in a TFSA would the dividends be subject to the 15% foreign withholding tax?
Thnx for your great service!!
Q: looking to buy some pharmaceutical stocks....can you please provide your 4 or 5 favs? or is there an ETF you would look at ? thank you...
Q: Please give me your opinion about TDOC (Teladoc). Is it a good sector to invest for long term.
Q: What do you think of the financing deal? Worth participating in for a high risk 2% allocation? Any visibility on them generating any revenue?
Q: There is only 1 question on ATRS that came up on the symbol search but no answer to the question was shown. So apologies for duplication but was wondering... What is your opinion of ATRS as a 1-2 year hold in a growth portfolio?
Thanks
Thanks
Q: Hello 5i team,
I want to buy Covalon in my TFSA. Would you suggest buying now or waiting for a possible pullback. It has had a big runup lately.
Thanks
I want to buy Covalon in my TFSA. Would you suggest buying now or waiting for a possible pullback. It has had a big runup lately.
Thanks
Q: Was doing some research on COV and noticed back in 2007 timeframe the stock was in the mid thirty dollar range. Is that accurate and was it just mis management which caused the decline? They have very strong products and I like the addition to the growth portfolio but was curious about the past.